IIT Study on the Use of Medical Bio Glue for Repairing Meniscus Tears
Launched by FIRST AFFILIATED HOSPITAL OF NINGBO UNIVERSITY · Mar 13, 2025
Trial Information
Current as of April 29, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The patient is aged between 18 and 60 years old (including 18 and 60 years old), regardless of gender; 2. Unilateral meniscus tear of the knee joint; 3. Normal joint range of motion; 4. The subjects agree to participate in this trial and sign the "Subject Informed Consent Form".
- Exclusion Criteria:
- • 1. Body mass index BMI\>32 kg/m2 (BMI=weight divided by height squared); 2. Patients with abnormal lower limb force lines that require correction; 3. Patients with multiple ligament injuries or complete meniscectomy; 4. Individuals with a history of allergies to biological glue as the chief complaint; 5. Patients with more than 2 or extensive cartilage defects in a single knee joint, and patients with bilateral knee joint cartilage defects; 6. Those who have undergone open knee surgery within the past 6 months; 7. Pregnant or lactating women, or those who plan to conceive during the trial period, and those whose blood HCG test results are positive before the trial; 8. Patients with infectious, immune, or metabolic arthritis in the knee joint; 9. Patients who participated in any other clinical trial or did not reach the trial endpoint within the first 3 months prior to enrollment; 10. Other circumstances determined by the researcher to be unsuitable for inclusion in this study.
About First Affiliated Hospital Of Ningbo University
The First Affiliated Hospital of Ningbo University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge medical practices with academic rigor, fostering collaborations between healthcare professionals and researchers. With a commitment to enhancing patient outcomes, the hospital focuses on a wide range of therapeutic areas, employing state-of-the-art facilities and methodologies to ensure the highest standards of clinical care and scientific integrity. Its mission is to contribute to the global medical community by developing effective treatments and improving health management strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ningbo, Zhejiang, China
Patients applied
Trial Officials
Jiang Zhu
Study Chair
First Affiliated Hospital of Ningbo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported